In this interview, we discuss public health and music playlists with Natasha Crowcroft, Chief of Applied Immunization Research and Evaluation at Public Health Ontario and Professor in Laboratory Medicine and Pathobiology and the Dalla Lana School of Public Health at the University of Toronto.
We speak to the Aaron Hoyles, the Program Manager of Break Dengue about their disease-surveillance tool, Dengue Track, eHealth and their plans for the future.
In this interview with Patrick Harris, from the University of Queensland, we discuss his role in setting up and co-ordinating the MERINO trial, and his research on the use of genomics in clinical microbiology.
In this interview, Roy Anderson, Director for the London Centre for Neglected Tropical Disease Research speaks about the work undertaken by the Centre and gives his thoughts on the wider NTD field.
Helen McShane discusses her work leading the TB vaccine research program at Oxford University, and shares her thoughts on the challenges facing vaccine development and eradication of this disease.
Reporting from ECCMID17, we spoke to William Irving about his current work on hepatitis C and his thoughts on the future of this field.
In this interview, Joop Arends discusses his thoughts on the future of diagnosis and management of hepatitis C, and also gives us his highlights from ECCMID.
Michael Pender discusses promising interim findings from a Phase 1 study investigating a novel treatment for multiple sclerosis based on the realtionship with Epstein–Barr virus.
In line with Hepatitis Awareness Month, we spoke to Marcus Dorner about his current research into the host–virus interactions in hepatitis B and C infection, their implications for vaccine development and more.
John-Arne Røttingen discusses his role as founding CEO of the Coalition for Epidemic Preparedness Innovations (CEPI) and his thoughts on the importance of developing new vaccines for emerging threats.